C000218695 Performance — Thrivent Mid Cap Value Portfolio, Class A
Data updated: 2026-08-26
C000218695 returned +18.99% year to date and +32.61% over one year to Jun 2026. Annualised returns are +15.75% over 3 years and +10.96% over 5 years. The fund beat its US Mid-Cap Value category average: $100 invested three years ago grew to $155, against $148 for the category, and to $133 over one year, against $120. Volatility over the past three years was 15.24% a year. In the 12 months to Jun 2026 the fund lost a net $3.4M, and assets reached $57.15M.
C000218695 Growth of $100
What $100 invested in Thrivent Mid Cap Value Portfolio grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Value category average over the same months.
| Period | C000218695 | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $133 | $120 |
| 3 years (Jul 2023 – Jun 2026) | $155 | $148 |
| 5 years (Jul 2021 – Jun 2026) | $168 | $154 |
| Since data start (Apr 2020 – Jun 2026) | $280 | $271 |
C000218695 Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +18.99% |
| 1 year | +32.61% |
| 3 years (annualised) | +15.75% |
| 5 years (annualised) | +10.96% |
C000218695 Annual Returns
Calendar-year total returns of Thrivent Mid Cap Value Portfolio, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +18.99% |
| 2025 | +10.82% |
| 2024 | +9.72% |
| 2023 | +13.31% |
| 2022 | −5.23% |
| 2021 | +30.88% |
| 2020 (Apr–Dec) | +37.55% |
C000218695 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +4.8% | +4.5% | −5.2% | +8.5% | +1.5% | +4.1% | — | — | — | — | — | — |
| 2025 | +3.8% | −2.9% | −4.6% | −5.2% | +4.5% | +4.5% | +2.6% | +2.3% | +1.7% | −0.1% | +3.6% | +1.0% |
| 2024 | −1.3% | +3.1% | +4.3% | −5.7% | +4.1% | −2.1% | +4.6% | −0.1% | +2.9% | +0.3% | +7.5% | −7.3% |
| 2023 | +8.5% | −3.0% | −3.9% | 0.0% | −3.6% | +8.5% | +4.7% | −4.3% | −3.8% | −5.0% | +8.8% | +7.6% |
| 2022 | −2.2% | +2.5% | +0.8% | −4.2% | +3.1% | −9.5% | +7.7% | −3.2% | −8.7% | +9.7% | +5.9% | −5.0% |
| 2021 | +1.1% | +9.9% | +5.8% | +3.6% | +1.4% | −2.1% | −0.4% | +2.0% | −1.9% | +5.1% | −2.9% | +6.5% |
| 2020 | — | — | — | 0.0% | +5.8% | +0.3% | +2.2% | +3.6% | −4.3% | +2.6% | +17.2% | +6.3% |
C000218695 Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 15.24%
- 3-year Sharpe ratio: 0.74 (vs 4.5% risk-free rate)
- Best month: +8.84% (Nov 2023)
- Worst month: −7.31% (Dec 2024)
C000218695 Fund Flows
Monthly money in and out of Thrivent Mid Cap Value Portfolio, from SEC Form N-PORT.
- 12-month net flow: −$3.4M
- 12-month gross sales (incl. reinvestments): $6.9M
- Sales ÷ redemptions: 0.67×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $2.7M | $462K | $2.2M |
| May 2026 | $916K | $444K | $472K |
| Apr 2026 | $555K | $649K | −$93K |
| Mar 2026 | $626K | $787K | −$161K |
| Feb 2026 | $321K | $1.3M | −$991K |
| Jan 2026 | $572K | $744K | −$172K |
| Dec 2025 | $333K | $811K | −$478K |
| Nov 2025 | $216K | $891K | −$674K |
| Oct 2025 | $339K | $955K | −$615K |
| Sep 2025 | $83K | $1.5M | −$1.4M |
| Aug 2025 | $97K | $612K | −$516K |
| Jul 2025 | $172K | $1.2M | −$1.0M |
C000218695 Assets Under Management
Net assets of Thrivent Mid Cap Value Portfolio by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $57.15M |
| 2026-03-31 | $49.85M |
| 2025-12-31 | $49.24M |
| 2025-09-30 | $48.92M |
| 2025-06-30 | $48.63M |
| 2025-03-31 | $46.89M |
| 2024-12-31 | $49.86M |
| 2024-09-30 | $50.95M |
| 2024-06-28 | $49.73M |
| 2024-03-28 | $52.53M |
| 2023-12-29 | $52.26M |
| 2023-09-29 | $48.36M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.